AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014.
Australia, 20 May 2014. Link here.
Read more about Avita Medical appoints new Chairman
Regenerative medicine company Avita Medical Limited “Avita Medical” (ASX:AVH) is pleased to announce that its product, ReCell, has been proven in a clinical study in Germany to provide clinically superior results for the treatment of hypopigmented scars.
Union MedTech plc today announces it is to be admitted to the AIM market of the London Stock Exchange with a market capitalisation of £25.7 million. On Admission, the acquisition by Union MedTech of REX Bionics Limited (“REX Bionics”) will complete and the Company will change its name to Rex Bionics plc.